Results 71 to 80 of about 4,418 (114)
Some of the next articles are maybe not open access.
Proceedings of the National Academy of Sciences of the United States of America, 2023
Fredrik Piehl +2 more
exaly
Fredrik Piehl +2 more
exaly
CD20+ T cells: an emerging T cell subset in human pathology
Inflammation Research, 2022Adrian Y S Lee, Lee Adrian Y S
exaly
CD20 as a gatekeeper of the resting state of human B cells
Proceedings of the National Academy of Sciences of the United States of America, 2021Michael Reth +2 more
exaly
International MS journal, 2008
Immune modulators, such as interferon beta and glatiramer acetate, have focused on T-cells as the primary therapeutic target, although both drugs affect other cell types as well. There has been a renewed interest in the potential roles of both antibody-dependent and antibody-independent B-cell responses in multiple sclerosis (MS) and its animal model ...
openaire +1 more source
Immune modulators, such as interferon beta and glatiramer acetate, have focused on T-cells as the primary therapeutic target, although both drugs affect other cell types as well. There has been a renewed interest in the potential roles of both antibody-dependent and antibody-independent B-cell responses in multiple sclerosis (MS) and its animal model ...
openaire +1 more source
Molecular mechanisms of B lymphocyte depletion by CD20 immunotherapy
Japanese Journal of Clinical Immunology, 2009Yasuhito Hamaguchi
exaly
The applications of anti-CD20 antibodies to treat various B cells disorders
Biomedicine and Pharmacotherapy, 2019Azam Rahimpour +2 more
exaly